---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-037953"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2024-09-24T23:59:59+00:00"
generated_at: "2026-05-31T02:01:18.725039+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# TRxADE Health renamed Scienture Holdings; ticker changes to SCNX on Nasdaq

## Summary
- Name change effective September 23, 2024; new CUSIP 80880X104.
- Stock now trades on Nasdaq under ticker SCNX; old ticker MEDS discontinued.
- Prior all-stock business combination with Scienture LLC valued at $103 million.
- Executive team and board unchanged; Suren Ajjarapu remains CEO and Chairman.
- Subsidiaries include Scienture LLC (specialty pharma) and Integra Pharma Solutions (wholesale).

## SEC filing metadata
- accession: 0001493152-24-037953
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2024-09-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315224037953/0001493152-24-037953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315224037953/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-037953
- JSON: https://secwatch.observer/filing/0001493152-24-037953.json
- Plain text: https://secwatch.observer/filing/0001493152-24-037953.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.